Earnings Labs
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC)

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$0.27

-4.18%

Mkt Cap $2.48M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 30, 2026

$15.66M$11.42M-27.08%$0.09-$0.86-1100.47%
Q4 2025

Nov 13, 2025

$14.27M$9.93M-30.40%-$0.02-$0.54-2234.63%
Q3 2025

Aug 12, 2025

$12.88M$9.32M-27.63%-$0.14-$0.07+48.79%
Q2 2025

May 15, 2025

$11.48M$8.78M-23.56%-$0.25$0.06+123.56%
Q1 2025

Mar 31, 2025

$10.09M$9.27M-8.15%-$0.39-$0.23+41.03%
Q4 2024

Nov 14, 2024

$14.48M$10.23M-29.37%-$0.70-$0.30+57.14%
Q3 2024

Aug 14, 2024

$9.57M$10.79M+12.73%-$0.84-$0.17+79.76%
Q2 2024

May 8, 2024

$10.60M$8.88M-16.20%-$0.96-$0.96+0.00%
Q1 2024

Mar 28, 2024

$12.06M$8.05M-33.23%-$0.96-$1.08-12.50%
Q4 2023

Nov 13, 2023

$10.45M$9.13M-12.61%-$0.96-$0.72+25.00%
Q3 2023

Aug 14, 2023

$13.44M$9.97M-25.82%-$0.78-$1.14-46.15%
Q2 2023

May 15, 2023

$13.80M$9.74M-29.46%-$1.20$0.12+110.00%
Q1 2023

Mar 29, 2023

$11.14M$10.78M-3.25%-$0.28-$1.32-371.43%
Q4 2022

Nov 14, 2022

$18.40M$10.35M-43.76%-$3.60-$3.00+16.67%
Q3 2022

Aug 15, 2022

$20.58M$18.49M-10.12%-$1.80-$14.40-700.00%
Q2 2022

May 12, 2022

$19.94M$10.40M-47.86%-$1.20-$7.80-550.00%
Q1 2022

Mar 31, 2022

$14.53M$15.71M+8.12%-$1.80-$9.00-400.00%
Q4 2021

Nov 24, 2021

$155.44M$6.34M-95.92%-$0.60-$8.40-1300.00%
Q3 2021

Aug 16, 2021

$8.96M-$0.20-$2.30-1050.00%
Q2 2021

May 18, 2021

$6.98M-$0.60